<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00622791</url>
  </required_header>
  <id_info>
    <org_study_id>802-01</org_study_id>
    <nct_id>NCT00622791</nct_id>
  </id_info>
  <brief_title>Propofol Pharmacokinetics and Pharmacodynamics During Cardiopulmonary Bypass</brief_title>
  <official_title>Effects of Cardiopulmonary Bypass on Plasma Propofol Concentrations and Bis Values During Coronary Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiopulmonary bypass (CPB) is known to alter pharmacokinetics (PK) and brain sensitivity to
      several drugs, including propofol. Few studies, however, have tested if propofol
      pharmacokinetical alterations observed after CPB could contribute to the increased hypnotic
      effect of propofol after CPB. This study was designed to test the hypothesis that changes in
      the PK of propofol contribute to an increase in its hypnotic effects after CPB as evidenced
      by changes in bispectral index (BIS) values.

      Twenty undergoing coronary artery bypass graft patients will be allocated in two groups: 1)
      CPB groups and 2) off-pump coronary artery bypass graft. Bispectral Index values and blood
      samples for plasma propofol concentration measurements will be collected along the surgery
      and up to 12 hours in the post-operative period. Plasma propofol concentrations, Bispectral
      index values and propofol PK will be compared between the groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Propofol pharmacodynamics and pharmacokinetics</measure>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <condition>Coronary Artery Bypass Graft</condition>
  <arm_group>
    <arm_group_label>CABG group</arm_group_label>
    <description>Patients undergoing coronary artery bypass graft with cardiopulmonary bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OPCAB group</arm_group_label>
    <description>Patients undergoing off-pump coronary artery bypass graft</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Twenty patients undergoing elective coronary artery bypass graft surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Isolated coronary artery bypass indication

          -  Left ventricular ejection fraction greater than 50 %

          -  Absence of preoperative pulmonary dysfunction

        Exclusion Criteria:

          -  Intra and postoperative circulatory shock

          -  Postoperative pulmonary dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria M Carmona, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina da Universidade de São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2008</study_first_submitted>
  <study_first_submitted_qc>February 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2008</study_first_posted>
  <last_update_submitted>February 13, 2008</last_update_submitted>
  <last_update_submitted_qc>February 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>Maria J. C. Carmona</name_title>
    <organization>Faculdade de Medicina da Universidade de São Paulo</organization>
  </responsible_party>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>coronary artery bypass graft</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>propofol</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>pharmacodynamics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

